Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Thus, this systematic review aimed to evaluate the effect of vitamin D supplementation on relapse rate and magnetic resonance imaging (MRI) disease activity in adults with clinically diagnosed MS.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Systematic review.

Systematic review

Uses explicit methods to identify, assess and summarise research on a defined question.

Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Vitamin D Supplementation and its Effect on Relapse Frequency and MRI Activity in Adults With Multiple Sclerosis: A Systematic Review

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vitamin D Supplementation and its Effect on Relapse Frequency and MRI Activity in Adults With Multiple Sclerosis: A Systematic Review

Systematic review · Brain and Behavior · 2026

Original publication title

Vitamin D Supplementation and its Effect on Relapse Frequency and MRI Activity in Adults With Multiple Sclerosis: A Systematic Review

Kamren Hall; Jessica Renteria; Elizabeth Fernandez; Janique Abrahams; Saajan Bhakta

© 2026 The Author(s). Brain and Behavior published by Wiley Periodicals LLC.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Vitamin D supplementation does not consistently reduce relapse rates in adults with MS, although some studies report improvement in MRI activity. The overall certainty of evidence is limited by variation in study design, patient population, cohort size, and risk of bias. Current data does not support vitamin D as a disease‐modifying therapy beyond correction of deficiency; further, larger, standardized trials are needed to clarify its clinical role.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Literature evidence links vitamin D supplementation to clinical outcomes in multiple sclerosis (MS), yet no systematic review has focused specifically on relapse rate and MRI activity. Thus, this systematic review aimed to evaluate the effect of vitamin D supplementation on relapse rate and magnetic resonance imaging (MRI) disease activity in adults with clinically diagnosed MS.

Source: Introduction

Abstract: What methods does the paper describe?

This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta‐Analysis (PRISMA) guidelines. PubMed, Cochrane, EBSCO, and Web of Science were searched for studies discussing vitamin D supplementation in adults with diagnosed MS. Annualized relapse rate (ARR) and changes in MRI activity were the primary outcome measures. Non‐randomized studies and randomized controlled trials were assessed for their risk of bias using the Cochrane ROBINS‐I and RoB‐2 tools, respectively.

Source: Methods

Abstract: Results

Of 304 records identified, 127 duplicates were removed and 177 were screened, with 11 primary studies (14 reports) included after full‐text review. Across studies, vitamin D supplementation did not suggest a reduced ARR with most randomized trials reporting no significant difference between groups. One trial using alfacalcidol provides evidence for a reduction in relapse risk, but this was not replicated. MRI outcomes were more variable, with several studies showing reductions in inflammatory lesion activity, while others found no significant effect.

Overall, results were inconsistent, and due to heterogeneity in study design and reporting, findings were synthesized narratively without meta‐analysis.

Source: Results

Abstract: Conclusion

Vitamin D supplementation does not consistently reduce relapse rates in adults with MS, although some studies report improvement in MRI activity. The overall certainty of evidence is limited by variation in study design, patient population, cohort size, and risk of bias. Current data does not support vitamin D as a disease‐modifying therapy beyond correction of deficiency; further, larger, standardized trials are needed to clarify its clinical role.

Source: Conclusion
Authors’ abstract

ABSTRACT

Introduction

Literature evidence links vitamin D supplementation to clinical outcomes in multiple sclerosis (MS), yet no systematic review has focused specifically on relapse rate and MRI activity. Thus, this systematic review aimed to evaluate the effect of vitamin D supplementation on relapse rate and magnetic resonance imaging (MRI) disease activity in adults with clinically diagnosed MS.

Methods

This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta‐Analysis (PRISMA) guidelines. PubMed, Cochrane, EBSCO, and Web of Science were searched for studies discussing vitamin D supplementation in adults with diagnosed MS. Annualized relapse rate (ARR) and changes in MRI activity were the primary outcome measures. Non‐randomized studies and randomized controlled trials were assessed for their risk of bias using the Cochrane ROBINS‐I and RoB‐2 tools, respectively.

Results

Of 304 records identified, 127 duplicates were removed and 177 were screened, with 11 primary studies (14 reports) included after full‐text review. Across studies, vitamin D supplementation did not suggest a reduced ARR with most randomized trials reporting no significant difference between groups. One trial using alfacalcidol provides evidence for a reduction in relapse risk, but this was not replicated. MRI outcomes were more variable, with several studies showing reductions in inflammatory lesion activity, while others found no significant effect.

Overall, results were inconsistent, and due to heterogeneity in study design and reporting, findings were synthesized narratively without meta‐analysis.

Conclusion

Vitamin D supplementation does not consistently reduce relapse rates in adults with MS, although some studies report improvement in MRI activity. The overall certainty of evidence is limited by variation in study design, patient population, cohort size, and risk of bias. Current data does not support vitamin D as a disease‐modifying therapy beyond correction of deficiency; further, larger, standardized trials are needed to clarify its clinical role.

Publication and source details

Original title: Vitamin D Supplementation and its Effect on Relapse Frequency and MRI Activity in Adults With Multiple Sclerosis: A Systematic Review

Kamren Hall; Jessica Renteria; Elizabeth Fernandez; Janique Abrahams; Saajan Bhakta

Brain and Behavior · 2026

© 2026 The Author(s). Brain and Behavior published by Wiley Periodicals LLC.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-08T18:24:42+00:00

DOI: 10.1002/brb3.71692 · PMC13486959